AMG133 is a monoclonal antibody drug designed to block the glucose-dependent insulinotropic polypeptide (GIP) receptor and simultaneously bind to two modified GLP-1 peptide segments to activate the GLP-1 receptor
Recognized by regulatory NABL bodies, Third-party certification means that an independent organisation has reviewed the manufacturing process of the product and has independently determined that the final product complies with specific standards for safety, quality and performance
L2-Cmu reduces cancer and improves survival in females In a 6 mo interim intervention trial with L2-Cmu in older mice, we performed an extensive histopathologic analysis and noted a reduction in endometrial hyperplasia severity (Supplementary Fig
Wuttke, W., Jarry, H., Haunschild, J., Stecher, G., Schuh, M., & Seidlova-Wuttke, D
How to take Bydureon BCise Bydureon BCise is an injection you give yourself once a week using a prefilled pen